The funding transition that catches most first-time founders off guard

You raised your first round. Angels backed you. A small privately backed fund came in alongside them. These investors moved on personal conviction - they believed in you, they shared your vision, and they made their decisions quickly. The money landed, the cap table took shape, and the business started to move.

Now you're preparing for your next round, this time with a VC. Your ask is bigger, but your story is sharper. You've made clear progress, and you know how to pitch. Why would the outcome be any different this time?

Because the person across the table answers to a completely different set of pressures. They aren't deciding whether they believe in you. They're deciding whether they can build an investment case that will survive the scrutiny of colleagues whose job is to find the holes. If you don't understand those pressures before you walk in, you will spend months in a process that was never going to close.

The divide you can't see from the outside

Most founders think of fundraising as a single skill they refine over time. Get better at pitching. Sharpen the deck. Improve the numbers.

But the more consequential transition isn't about getting better at the same game. It's recognising that the game itself has changed.

The real divide in venture fundraising isn't between rounds. It's between investor types. On one side are investors who deploy their own capital, or capital from a small group of private backers, and who decide based on their belief in the founder's vision. On the other are investors who manage institutional money - funds with external limited partners, formal committees, and a mandate to justify every allocation.

Both types can invest at Seed. Both can invest at Series A. But that is where the similarity ends. The difference between them is invisible from the outside - which is precisely why it catches founders off guard. A founder who closed their first round with conviction-based investors may walk into their next meeting expecting the same dynamics - and discover, mid-process, that everything about how the decision gets made is different.

The partner loves you. But the partner isn't the decision-maker. And that distinction changes everything.

Inside the machine: why your champion isn't enough

When a conviction-based investor backs you, the person you pitched is the person who decides. In an institutional fund, that partner becomes your champion - but the decision happens elsewhere.

They must take your opportunity to an investment committee: a room of people who haven't met you, whose job is to pressure-test every assumption, and who are evaluating your deal against every other opportunity competing for the same pool of capital.

This changes your job fundamentally. You are no longer selling yourself to the person across the table. You are equipping that person to sell your opportunity to their colleagues - arming them with the evidence, the market logic, and the narrative they need to win an internal argument on your behalf.

That means your materials need to work in a room where you aren't present. Your data needs to withstand scrutiny from people who are looking for reasons to say no.

Founders who don't grasp this dynamic spend months building a relationship with a partner who personally loves the deal but cannot get it through committee. It's one of the most common - and most demoralising - failure modes in early-stage fundraising.

The DeepTech double bind

For DeepTech founders, this transition is amplified by a structural gap in investor capability. The 2026 European DeepTech Report's investor analysis mapped 549 investors across 115 specialist European funds and found that only 52.5% hold a STEM-related degree. At the fund level, just 20% have fully technical investment teams. Operator experience from the sector is rarer still.

The DeepTech founder moving from an angel who understands the science to an institutional fund faces a double bind: not just the shift from conviction-based to committee-based decision-making, but the need to translate complex technology into a commercial thesis for investors who may not be equipped to independently verify the technical claims.

This is where the tension between scientific rigour and commercial storytelling becomes acute. Many technical founders instinctively respond by going deeper into the science - more detail, more precision, more proof of technical sophistication. But that impulse works against them. What the committee needs isn't technical depth. It's commercial clarity.

And this matters not just for the written materials. Before a final decision is made, institutional funds will often ask the founding team to present directly to their investment committee. That is a room where your champion has already made the case on paper. Your job in that moment is to reinforce the commercial conviction - not to deliver a seminar on the underlying physics.

The founders who stumble here are those who assume a specialist DeepTech fund means a technically fluent investment committee. It usually doesn't. The burden of translation sits with you - and the quality of that translation determines whether your champion can carry the deal.

The timeline trap

Unlike the small private rounds, time is now the hidden killer. Institutional decision-making takes longer by design - partner meetings, investment committee cycles, due diligence processes, legal negotiation.

And the metrics bar keeps rising, which means founders need more runway to hit the thresholds institutional investors demand before they can even begin the process. According to Carta's latest data, the median time from seed to Series A has now hit 2.2 years - and stretching. For founders outside AI, the wait is often longer still.

For DeepTech founders already operating on longer R&D cycles, this creates an acute vulnerability. Enter an institutional process without sufficient runway to survive a protracted timeline, and desperation becomes visible.

As we explored in an earlier issue, desperate founders don't get funded - not because they lack merit, but because the signals of urgency undermine the confidence institutional investors need to commit.

The irony is painful: the founders most in need of capital are the ones least likely to secure it, because the institutional process rewards patience and penalises pressure. The most common failure mode isn't outright rejection. It's running out of time and cash before a decision is made - a slow fade that leaves founders wondering what went wrong when the answer is simply that they started too late.

Looking for reasons to invest - or reasons not to

Here is the distinction that changes everything once you truly absorb it.

Early-stage conviction-based investors - angels, small private funds, founder-backers - are looking for reasons to invest. If they are excited by the founder and can see the vision, they lean in. The deck matters, but it's the founder who closes the deal. The market sizing doesn't need to be bulletproof. The business model can be provisional. The go-to-market plan can be directional. These investors are buying into potential, and they accept the ambiguity that comes with it.

Institutional investors operate with the opposite instinct. They are looking for reasons not to invest. Every element of the proposition - the market, the business model, the competitive landscape, the unit economics, the go-to-market plan, the team's ability to execute - must withstand scrutiny. Not because institutional investors are cynical, but because the committee process is designed as a filter. Each member will have their own areas of focus and will grill the sponsoring partner on them.

This means the founder's job is not simply to present a compelling story. It is to understand, in advance, what each dimension of scrutiny will look like - and to ensure their champion walks into committee armed with answers, not exposed to questions they cannot handle.

The founders who prepare their sponsoring partner properly - anticipating the objections, stress-testing the weaknesses, providing the evidence that addresses each concern before it's raised - are the ones who get through. Those who assume the same pitch that won over their angels will carry the day in committee are the ones who stall.

Your earliest investors shape your institutional odds

Perhaps the most actionable insight for founders navigating this transition is how much the choice of early investor affects your chances of making the institutional leap.

Dealroom's research on European early-stage investment found that startups backed by top-quartile seed investors had a 40% graduation rate to Series A, compared with just 7% for those backed by bottom-quartile investors. A nearly six-fold difference driven by a single early decision.

The implication is striking. Choosing your angels and Seed investors strategically - for their ability to make warm introductions to institutional capital, provide the credibility signal that institutional investors look for, and help you prepare for the rigour ahead - may be the most underrated decision a first-time founder makes.

The right early investors don't just fund you; they help build the bridge to the institutional round. Without that bridge, the leap becomes a fall.

The game behind the game

The institutional leap isn't a bigger version of what came before. It's a different game with different rules, different decision-makers, and a different definition of what makes an opportunity investable.

The founders who navigate it successfully aren't necessarily the ones with the best technology or the most impressive metrics. They're the ones who understood, before they walked into the room, exactly who they were talking to - and what that person needed to hear.

If there is one thing to take from this, it's that the time to prepare for the institutional round is long before you need one. Learn the dynamics, build the relationships, and choose your early investors as if your next round depends on them. Because it often does.

 
Let's talk.